Sofia Menshikova/LinkedIn
Apr 11, 2025, 10:20
Sofia Menshikova: Understanding the Clinical Implications of HER2-Low – A Quick and Accessible Read
Sofia Menshikova, Medical Excellence Manager, Medical Affairs Division at BostonGene, shared on LinkedIn:
“Hi all,
Excited to share our new blog post on Nature Communities – ‘Beware, HER2-low breast cancer – we see you!’
A quick and accessible read that walks through the clinical implications of HER2-low, the evolving landscape, and how BostonGene can support care in this space.
Read it here.
Let us know what you think!
With Vladimir Kushnarev and Sheila Yong”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 14, 2025, 09:32
Apr 14, 2025, 09:30
Apr 14, 2025, 09:15
Apr 14, 2025, 09:04
Apr 14, 2025, 09:03